Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III TQC2731 in Chronic Rhinosinusitis with Nasal Polyps
ChiCTR2500107905Phase 3Not yet recruiting
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Aug 2025
- Modality
- IgG Antibodies → Naked Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing TQC2731 + mometasone furoate with Placebo + mometasone furoate (2 arms). Primary endpoints: Change in Nasal Polyp Score (NPS) and Change in Nasal Congestion Score (NCS). Planned start Aug 2025; status: not yet recruiting.
02
Drugs
bosakitug
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on ChiCTR2500107905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107905.